IFP Advisors Inc Decreases Stock Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

IFP Advisors Inc trimmed its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 26.3% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,182 shares of the exchange traded fund’s stock after selling 1,135 shares during the period. IFP Advisors Inc’s holdings in SPDR S&P Biotech ETF were worth $258,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Cerity Partners LLC grew its position in shares of SPDR S&P Biotech ETF by 5.8% during the first quarter. Cerity Partners LLC now owns 18,605 shares of the exchange traded fund’s stock worth $1,509,000 after buying an additional 1,016 shares in the last quarter. Alliancebernstein L.P. bought a new position in SPDR S&P Biotech ETF during the 4th quarter valued at $607,000. Golden State Wealth Management LLC grew its holdings in SPDR S&P Biotech ETF by 100.0% during the 1st quarter. Golden State Wealth Management LLC now owns 638 shares of the exchange traded fund’s stock worth $52,000 after acquiring an additional 319 shares in the last quarter. Dynamic Advisor Solutions LLC bought a new stake in shares of SPDR S&P Biotech ETF in the 1st quarter worth about $825,000. Finally, O Shaughnessy Asset Management LLC increased its position in shares of SPDR S&P Biotech ETF by 38.6% in the 4th quarter. O Shaughnessy Asset Management LLC now owns 718 shares of the exchange traded fund’s stock worth $65,000 after purchasing an additional 200 shares during the last quarter.

SPDR S&P Biotech ETF Stock Performance

Shares of XBI stock opened at $87.61 on Monday. The stock has a market capitalization of $4.74 billion, a price-to-earnings ratio of 11.47 and a beta of 0.97. SPDR S&P Biotech ETF has a one year low of $66.66 and a one year high of $105.47. The company’s 50-day simple moving average is $83.69 and its 200-day simple moving average is $84.28.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.